EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glucagon-Like Peptide-1 Receptor Agonists and Medicaid: Insights From Policy and Prescription Data

Rachel Y L Fung iD, Lauren Tonti iD, Michael F Pesko iD

Medical Care Research and Review · 27.10.2026

DOI: 10.1177/10775587261494447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Care Research and Review, online erschienen am 27.10.2026. Verfasst von Rachel Y L Fung und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri, Columbia, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: national institutes of health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

State Medicaid programs vary in whether they cover glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity treatment, creating an opportunity to examine how utilization differs across coverage environments. We combined 2024 KFF Medicaid coverage data with Medicaid State Drug Utilization Data from 2015 to 2024 across all 50 states and Washington, D.C. As of August 2024, 13 states covered GLP-1s for obesity, and prescriptions were concentrated in those states, reaching 16.2 per 1,000 Medicaid beneficiaries in Q4 2024. Prescription rates for obesity-indicated GLP-1s were higher in states with coverage and showed no consistent patterns across states with different utilization management requirements. GLP-1 prescriptions were more common in managed care than fee-for-service plans. GLP-1 prescribing varies substantially across state Medicaid coverage environments, underscoring the importance of monitoring how utilization evolves as state coverage policies change.

Schlagwörter

Stichwörter der Autor:innen

Medicaidanti-obesity agentsdrug utilizationglucagon-like peptide 1 receptor agonistsobesity / drug therapy

Autor:innen und Institutionen

  • University of Missouri, Columbia, USA.

ORCID-Profile: Rachel Y L Fung, Lauren Tonti, Michael F Pesko

Förderung

  • national institutes of health

Zitieren

APA

Fung, R. Y. L., Tonti, L., & Pesko, M. F. (2026). Glucagon-Like Peptide-1 Receptor Agonists and Medicaid: Insights From Policy and Prescription Data. Medical Care Research and Review. https://doi.org/10.1177/10775587261494447

Vancouver

Fung RYL, Tonti L, Pesko MF. Glucagon-Like Peptide-1 Receptor Agonists and Medicaid: Insights From Policy and Prescription Data. Medical Care Research and Review. 2026. doi:10.1177/10775587261494447

BibTeX
@article{Fung2026,
  author = {Fung, Rachel Y L and Tonti, Lauren and Pesko, Michael F},
  title = {Glucagon-Like Peptide-1 Receptor Agonists and Medicaid: Insights From Policy and Prescription Data},
  journal = {Medical Care Research and Review},
  year = {2026},
  doi = {10.1177/10775587261494447}
}
Kostenlos starten →